CLINICAL_TRIALS
trial_result
· 2017-10-20
Clinical Trial Update: Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial investigating treatment of the cholesterol defect in Smith-Lemli-Opitz Syndrome; status completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Boston Children's Hospital | Conditions: Smith-Lemli-Opitz Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-10-20